AI-Generated Summary This article by infectious diseases pharmacist Aneeka Chavda outlines five key considerations for pharmacists in the treatment of Mycobacterium tuberculosis (TB), particularly drug-sensitive cases. It emphasizes the critical but potentially underdosed role of rifampicin, highlighting research into higher doses that may improve outcomes. Ethambutol’s ocular … [Read more...]

In this article an infectious diseases anpharmacist discusses five inconvenient truths to know about infectious diseases.  Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP with an introduction by ChatGPT AI-Generated Summary: This article outlines five fundamental truths about infectious diseases, emphasizing their complexity and the … [Read more...]

In this article two infectious diseases pharmacists discuss five things to know about interpreting MRSA nares swab results   Authored By: Hunter Rondeau, Pharm.D., BCIDP & Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 16 April 2025 The methicillin-resistant Staphylococcus aureus (MRSA) nares swab (also referred to as a MRSA nasal swab) is a valuable … [Read more...]

In this article an infectious diseases pharmacist discusses some of many learning tidbits from ESCMID Global 2025, the largest international meeting of clinical microbiologists and infectious diseases specialists. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 16 April 2025 This year the European Society for Clinical … [Read more...]